*DJ CTI BioPharma Corp. Looks to Raise $50.7 Million via Stock Offer
(MORE TO FOLLOW) Dow Jones Newswires
March 31, 2021 23:53 ET (03:53 GMT)
*DJ CTI Offering 14,260,800 Shares of Common Stock, 600 Shares of Series X(1) Preferred Stock
(MORE TO FOLLOW) Dow Jones Newswires
March 31, 2021 23:54 ET (03:54 GMT)
*DJ CTI Common Stock Priced at $2.50 Each, Preferred Stock Priced at $25,000
(MORE TO FOLLOW) Dow Jones Newswires
March 31, 2021 23:55 ET (03:55 GMT)
*DJ CTI: Each Preferred Share Will Be Convertible Into 10,000 Common Shares
(MORE TO FOLLOW) Dow Jones Newswires
March 31, 2021 23:55 ET (03:55 GMT)
*DJ CTI Has Granted Underwriters Option for Additional 2,139,120 Common Shares
(MORE TO FOLLOW) Dow Jones Newswires
March 31, 2021 23:56 ET (03:56 GMT)
*DJ CTI Offering Is Expected to Close on or About April 6
(MORE TO FOLLOW) Dow Jones Newswires
March 31, 2021 23:56 ET (03:56 GMT)
*DJ CTI Intends to Use Proceeds for Commercialization Activities for Pacritinib
(MORE TO FOLLOW) Dow Jones Newswires
March 31, 2021 23:57 ET (03:57 GMT)
*DJ CTI: Pacritinib Is Sole Product Candidate in Active Development
(MORE TO FOLLOW) Dow Jones Newswires
March 31, 2021 23:58 ET (03:58 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.